Aaron G.L. Fletcher insider trades

Open-market stock purchases and sales by Aaron G.L. Fletcher, Director, 10% Owner at Cognition Therapeutics Inc, from SEC Form 4 filings since Sep 30, 2019.

Track record: 38% of 8 scored buys are up 5% or more since purchase, averaging -36%.

Recent trades

DateStockTradeValue
Jun 17, 2026CGTX Cognition Therapeutics IncBought (not open market)—
May 21, 2026ACTU Actuate Therapeutics, IncBought (not open market)—

Companies traded

  • CGTX Cognition Therapeutics Inc: 12 buys, 1 sale, last Jun 17, 2026
  • ACTU Actuate Therapeutics, Inc: 3 buys, 6 sales, last May 21, 2026
  • LTRN Lantern Pharma Inc: 61 sales, last Jun 13, 2025
  • [INAB In8bio, Inc: 1 buy, last May 2, 2025
  • INAB In8bio, Inc: 19 buys, last Oct 4, 2024
  • NGE C In8bio, Inc: 1 buy, last Dec 13, 2023
  • AZTR Azitra Inc: 6 buys, 3 sales, last Jun 21, 2023
  • CUE Cue Biopharma, Inc: 6 buys, last Jan 3, 2023
  • TFFP TFF Pharmaceuticals, Inc: 13 buys, last Dec 29, 2022
  • SWKH SWK Holdings Corp: other filings, last Dec 31, 2021

Get free alerts when Aaron G.L. Fletcher files a new trade →